col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Society for Clinical Investigation: JCI Insight
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―10 Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19 Alec A. Schmaier, Gabriel M. Pajares Hurtado, Zachary J. Manickas-Hill, Kelsey D. Sack, Siyu M. Chen, Victoria Bhambhani, et al. (+11)
2 [GO] 2021―Sep―10 More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals Sabrina E. Racine-Brzostek, Jim K. Yee, Ashley Sukhu, Yuqing Qiu, Sophie Rand, Paul D. Barone, et al. (+10)
3 [GO] 2021―Aug―31 Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2 transgenic mice Masamitsu N. Asaka, Daichi Utsumi, Haruhiko Kamada, Satoshi Nagata, Yutaka Nakachi, Tomokazu Yamaguchi, et al. (+3)
4 [GO] 2021―Aug―27 A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity Annemieke Smet, Tom Breugelmans, Johan Michiels, Kevin Lamote, Wout Arras, Joris G. De Man, et al. (+16)
5 [GO] 2021―Aug―17 Self-sustaining interleukin-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19 Rainer Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, et al. (+24)
6 [GO] 2021―Aug―17 Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long-COVID John P. Haran, Evan Bradley, Abigail L. Zeamer, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, et al. (+7)
7 [GO] 2021―Aug―10 SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8 Valentina Salvi, Hoang Oanh Nguyen, Francesca Sozio, Tiziana Schioppa, Carolina Gaudenzi, Mattia Laffranchi, et al. (+11)
8 [GO] 2021―Aug―06 Ex vitro SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses Matthew A. Schaller, Yamini Sharma, Zadia Dupee, Duy T. Nguyen, Juan M. Urueña, Ryan A. Smolchek, et al. (+7)
9 [GO] 2021―Jul―27 COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction Kimberly A. Queisser, Rebecca A. Mellema, Elizabeth A. Middleton, Irina Portier, Bhanu Kanth Manne, Frederik Denorme, et al. (+4)
10 [GO] 2021―Jul―21 L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus Yuji Kondo, Jason L. Larabee, Liang Gao, Huiping Shi, Bojing Shao, Christopher M. Hoover, et al. (+15)
11 [GO] 2021―Jul―20 Nucleocapsid-specific and PD-L1+CXCR3+ CD8 polyfunctional T-cell abundances are associated with survival of critical SARS-CoV2-infected patients Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, et al. (+8)
12 [GO] 2021―Jul―12 Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay Ester Lopez, Ebene R. Haycroft, Amy Adair, Francesca L. Mordant, Matthew T. O'Neill, Phillip Pymm, et al. (+15)
13 [GO] 2021―Jul―12 HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells Rabiah Fardoos, Osaretin E. Asowata, Nicholas Herbert, Sarah K. Nyquist, Yenzekile Zungu, Alveera Singh, et al. (+14)
14 [GO] 2021―Jul―09 SARS-CoV-2 infection of the pancreas promotes thrombo-fibrosis and is associated with new-onset diabetes Mirza Muhammad Fahd Qadir, Manika Bhondeley, Wandy Beatty, Dina D. Gaupp, Lara A. Doyle-Meyers, Tracy Fischer, et al. (+9)
15 [GO] 2021―Jul―08 Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration Sigrid Gouma, Madison E. Weirick, Marcus J. Bolton, Claudia P. Arevalo, Eileen C. Goodwin, Elizabeth M. Anderson, et al. (+12)
16 [GO] 2021―Jul―06 Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, et al. (+13)
17 [GO] 2021―Jun―29 IL-13 is a driver of COVID-19 severity Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, Saskia Preissner, Benjamin T. Bradley, Rebecca M. Carpenter, et al. (+21)
18 [GO] 2021―Jun―24 Autoantibodies stabilize neutrophil extracellular traps in COVID-19 Yu Zuo, Srilakshmi Yalavarthi, Sherwin A. Navaz, Claire K. Hoy, Alyssa Harbaugh, Kelsey Gockman, et al. (+5)
19 [GO] 2021―Jun―18 COVID-19 and RA share SPP1 myeloid pathway that drives PD-L1pos neutrophils and CD14pos monocytes Lucy MacDonald, Stefano Alivernini, Barbara Tolusso, Aziza Elmesmari, Domenico Somma, Simone Perniola, et al. (+20)
20 [GO] 2021―Jun―18 Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses Jacob K. Files, Sanghita Sarkar, Timothy R Fram., Sushma Boppana, Sarah Sterrett, Kai Qin, et al. (+6)
21 [GO] 2021―Jun―10 Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 Hyung J. Chun, Elias Coutavas, Alexander B. Pine, Alfred I. Lee, Vanessa L. Yu, Marcus K. Shallow, et al. (+6)
22 [GO] 2021―Jun―03 Epitope-specific antibody responses differentiate COVID-19 outcome and variants of concern Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Ackloo, Tomonori Kaneko, et al. (+20)
23 [GO] 2021―Jun―01 Cardiovascular complications of COVID-19 Farnaz Farshidfar, Navid Koleini, Hossein Ardehali
24 [GO] 2021―May―23 The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age Paula P. Freire, Alexandre H.C. Marques, Gabriela C. Baiocchi, Lena F. Schimke, Dennyson L.M. Fonseca, Ranieri C. Salgado, et al. (+17)
25 [GO] 2021―May―11 Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2 Reut Falach, Liat Bar-On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, et al. (+24)
26 [GO] 2021―May―09 A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients Samantha M. Morrissey, Anne E. Geller, Xiaoling Hu, David Tieri, Chuanlin Ding, Christopher K. Klaes, et al. (+19)
27 [GO] 2021―Apr―28 Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques Yongjun Sui, Jianping Li, Roushu Zhang, Sunaina Kiran Prabhu, Hanne Andersen Elyard, David Venzon, et al. (+19)
28 [GO] 2021―Apr―22 Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus Ami Patel, Emma L. Reuschel, Ziyang Xu, Faraz I. Zaidi, Kevin Y. Kim, Dana P. Scott, et al. (+17)
29 [GO] 2021―Apr―06 Natural mucosal barriers and COVID-19 in children Carl A. Pierce, Sharlene Sy, Benjamin Galen, Doctor Y. Goldstein, Erika P. Orner, Marla J. Keller, et al. (+2)
30 [GO] 2021―Apr―06 SARS-CoV-2 vaccines: a triumph of science and collaboration Jonathan L. Golob, Njira Lugogo, Adam S. Lauring, Anna S. Lok
31 [GO] 2021―Mar―23 Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure Alexis R. Demonbreun, Thomas W. McDade, Lorenzo L. Pesce, Lauren A. Vaught, Nina L. Reiser, Elena Bogdanovic, et al. (+11)
32 [GO] 2021―Mar―21 Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area Peter M. Thielen, Shirlee Wohl, Thomas Mehoke, Srividya Ramakrishnan, Melanie Kirsche, Oluwaseun Falade-Nwulia, et al. (+16)
33 [GO] 2021―Mar―15 A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2 Abdelilah Majdoubi, Christina Michalski, Sarah E. O’Connell, Sarah Dada, Sandeep R. Narpala, Jean P. Gelinas, et al. (+17)
34 [GO] 2021―Mar―02 Cell-free DNA maps COVID-19 tissue injury and risk of death, and can cause tissue injury Temesgen E. Andargie, Naoko Tsuji, Fayaz Seifuddin, Moon Kyoo Jang, Peter S.T. Yuen, Hyesik Kong, et al. (+9)
35 [GO] 2021―Feb―27 Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2 Krystle K.Q. Yu, Stephanie Fischinger, Malisa T. Smith, Caroline Atyeo, Deniz Cizmeci, Caitlin R. Wolf, et al. (+15)
36 [GO] 2021―Feb―11 Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma Michele L. Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, et al. (+42)
37 [GO] 2021―Feb―02 Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2 Lotfi Chouchane, Jean-Charles Grivel, Elmoubasher Farag, Igor Pavlovski, Selma Maacha, Abbirami Sathappan, et al. (+11)
38 [GO] 2021―Jan―26 Distinct antibody repertoires against endemic human coronaviruses in children and adults Taushif Khan, Mahbuba Rahman, Fatima Al Ali, Susie S.Y. Huang, Manar Ata, Qian Zhang, et al. (+19)
39 [GO] 2021―Jan―21 Rectifying COVID-19 disparities with treatment and vaccination John M. Carethers
40 [GO] 2021―Jan―21 Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors Yang Han, Peipei Liu, Yang Qiu, Jie Zhou, Ying Liu, Xujuan Hu, et al. (+13)
41 [GO] 2021―Jan―21 Treatment of Severe COVID-19 with Convalescent Plasma in Bronx, NYC Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, et al. (+49)
42 [GO] 2021―Jan―14 Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 Davide Scozzi, Marlene Cano, Lina Ma, Dequan Zhou, Ji Hong Zhu, Jane A. O’Halloran, et al. (+15)
43 [GO] 2021―Jan―10 Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022 Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John Burke, Alexandra Schäfer, Sarah R. Leist, et al. (+20)
44 [GO] 2020―Dec―07 Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2 induced systemic toxicity Shen Li, Feiyang Ma, Tomohiro Yokota, Gustavo Garcia Jr., Amelia Palermo, Yijie Wang, et al. (+18)
45 [GO] 2020―Nov―24 An immune-based biomarker signature is associated with mortality in COVID-19 patients Michael S. Abers, Ottavia M. Delmonte, Emily E. Ricotta, Jonathan Fintzi, Danielle Fink, Adriana A. de Jesus, et al. (+40)
46 [GO] 2020―Oct―22 Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models Kyle Rosenke, Michael A. Jarvis, Friederike Feldmann, Benjamin Schwarz, Atsushi Okumura, Jamie Lovaglio, et al. (+17)
47 [GO] 2020―Oct―09 Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors Cong Zeng, John P. Evans, Rebecca Pearson, Panke Qu, Yi-Min Zheng, Richard T. Robinson, et al. (+8)
48 [GO] 2020―Sep―16 High levels of SARS-CoV-2 specific T-cells with restricted functionality in severe course of COVID-19 David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp M. Lepper, Heinrike Wilkens, et al. (+7)
49 [GO] 2020―Sep―01 A simple protein-based surrogate neutralization assay for SARS-CoV-2 Kento T. Abe, Zhijie Li, Reuben Samson, Payman Samavarchi-Tehrani, Emelissa J. Valcourt, Heidi Wood, et al. (+17)
50 [GO] 2020―Aug―25 Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease Joseph W. Golden, Curtis R. Cline, Xiankun Zeng, Aura R. Garrison, Brian D. Carey, Eric M. Mucker, et al. (+11)
51 [GO] 2020―Aug―14 Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity Kathleen M. McAndrews, Dara P. Dowlatshahi, Jianli Dai, Lisa M. Becker, Janine Hensel, Laura M. Snowden, et al. (+13)
52 [GO] 2020―Jul―24 Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel A. Roque, Adijat Asuni, et al. (+9)
53 [GO] 2020―Jul―20 Severe immunosuppression and not a cytokine storm characterize COVID-19 infections Kenneth E. Remy, Monty Mazer, David A. Striker, Ali H. Ellebedy, Andrew H. Walton, Jacqueline Unsinger, et al. (+15)
54 [GO] 2020―Jun―19 COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, Travis Nemkov, Lorenzo Bertolone, Richard O. Francis, et al. (+6)
55 [GO] 2020―Jun―18 The complement system in COVID-19: friend and foe? Anuja Java, Anthony J. Apicelli, M. Kathryn Liszewski, Ariella Coler-Reilly, John P. Atkinson, Alfred H.J. Kim, Hrishikesh S. Kulkarni
56 [GO] 2020―Jun―16 IL-6 combined with CD8+ T cell count early predict in-hospital mortality for patients with COVID-19 Miao Luo, Jing Liu, Weiling Jiang, Shuang Yue, Huiguo Liu, Shuang Wei
57 [GO] 2020―Jun―12 New (re)Purpose for an old drug: purinergic receptor blockade may extinguish the COVID-19 thrombo-inflammatory firestorm Yogendra Kanthi, Jason S. Knight, Yu Zuo, David J. Pinsky
58 [GO] 2020―Jun―05 Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease Yan Zhao, Ling Qin, Ping Zhang, Kang Li, Lianchun Liang, Jianping Sun, et al. (+16)
59 [GO] 2020―May―19 Clinical and pathological investigation of severe COVID-19 patients Shaohua Li, Lina Jiang, Xi Li, Fang Lin, Yijin Wang, Boan Li, et al. (+17)
60 [GO] 2020―May―07 Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens Jun Liu, April M. Babka, Brian J. Kearney, Sheli R. Radoshitzky, Jens H. Kuhn, Xiankun Zeng
61 [GO] 2020―Apr―30 Characteristics and diagnosis rate of 5,630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China Na Shen, Yaowu Zhu, Xiong Wang, Jing Peng, Weiyong Liu, Feng Wang, et al. (+3)
62 [GO] 2020―Apr―24 Neutrophil extracellular traps in COVID-19 Yu Zuo, Srilakshmi Yalavarthi, Hui Shi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, et al. (+7)
63 [GO] 2020―Apr―23 The laboratory tests and host immunity of COVID-19 patients with different severity of illness Feng Wang, Hongyan Hou, Ying Luo, Guoxing Tang, Shiji Wu, Min Huang, et al. (+7)
64 [GO] 2020―Apr―17 COVID-19 in older adults: clinical, psychosocial, and public health considerations John P. Mills, Keith S. Kaye, Lona Mody


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.015 sec